ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 651850 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 651850; 2) Community: the network communities that were significantly associated with the response to NSC 651850; 3) Molecule: the relationships between components within communities and NSC 651850; 4) MDR: the compounds that were significantly associated with the NSC 651850.

NSC Compound Enrichment Correlation
NSC 736624 Indenoisoquinoline derivative 0.00103112124545271 0.54496248
NSC 333571 Benzoic acid, 3,4,5-trihydroxy-, phenyl ester 0.00140570135773563 0.55282483
NSC 606498 Camptothecin Derivative 0.00140570135773563 0.65044103
NSC 609699 Topotecan hydrochloride 0.00140570135773563 0.55107516
NSC 639186 Raltitrexed 0.00140570135773563 0.30647197
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.00140570135773563 0.36678776
NSC 681635 Camptothecin Derivative 0.00140570135773563 0.5566243
NSC 704651 Null 0.00140570135773563 0.28767939
NSC 617593 Methylene Blue 0.00159809164939554 -0.0832198
NSC 642328 Benzonitrile, 4-[[1,3,3a,4,9,9a-hexahydro-9-(4-hydroxy- 3,5-dimethoxyphenyl)-6,7-dimethoxy- 1-oxonaphtho[2,3-c]furan-4-yl]amino]-, [3aS-(3a.alpha.,4.beta.,9.alpha.,9a.beta.)]- (9CI) 0.00159809164939554 0.67129551
Total:52  Current:2    [First] [Prev] [Next] [Last]